SCHEMBL14939088

SCHEMBL14939088

CCOc1cccc(CN2CCN(C3(c4ccnc5ccccc45)C(=O)c4ccccc4C3=O)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.46
FAAH O00519 2/20 0.45
HTR1A P08908 2/20 0.44
DRD2 P14416 2/20 0.44
HTR2B P41595 1/20 0.44
ADAM17 P78536 1/20 0.41
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
GAA P10253 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
HIF1A Q16665 1/20 0.39
LMNA P02545 2/20 0.39
RAB9A P51151 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
ALOX12 P18054 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH3A1 P30838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14940079 0.92 SIGMAR1 (0.50) NPSR1FAAHHTR1ADRD2ALDH1A1
SCHEMBL14939769 0.85 NPSR1 (0.62) NPSR1FAAHHTR1ADRD2HTR2B
SCHEMBL14939501 0.83 HTR1A (0.49) NPSR1FAAHHTR1ADRD2HTR2B
SCHEMBL14939310 0.79 NPSR1 (0.46) NPSR1FAAHADAM17ALDH1A1KDM4E
SCHEMBL14939248 0.79 L3MBTL1 (0.53) FAAHHTR1ADRD2HTR2BALDH1A1
SCHEMBL14940163 0.79 NPSR1 (0.69) NPSR1FAAHHTR1ADRD2HTR2B
SCHEMBL14939152 0.79 KDM4E (0.44) NPSR1HTR1AALDH1A1KDM4ELMNA
SCHEMBL14939086 0.75 SIGMAR1 (0.50) NPSR1FAAHHTR1ADRD2HTR2B
SCHEMBL14939655 0.75 SIGMAR1 (0.52) NPSR1FAAHHTR1ADRD2HTR2B
SCHEMBL14939172 0.74 NPSR1 (0.53) NPSR1FAAHHTR1ADRD2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013068785-A1 INDANONE AND INDANDIONE DERIVATIVES AND HETEROCYCLIC ANALOGS ACTELION PHARMACEUTICALS LTD (CH) 2013-05-16 WO disclosed